VanEck
CYBO.SW
IE0005TF96I9
VanEck Medical Robotics and Bionic Engineering UCITS ETF
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
29.75
Weighted Fwd P/E
20.72
Avg P/FCF
27.65
Avg FCF Yield
3.46%
Avg EV / EBITDA
21.27
Avg EV / Revenue
7.2
Avg Price-to-Book (P/B)
5.72
Avg Price-to-Sales (P/S)
5.6
Avg Dividend Yield
0.01%
P/E Compression (Trailing vs Fwd)
-30.35%
Avg Debt-to-Equity (D/E)
184.43%
<50% (31.22%) 50-150% (51.29%) >150% (6.21%) Unreported (11.28%)

Profitability Analysis

25 Holdings Count
Profitable 97.98%
Profitable 97.98%
23 Holdings Count (92%)
Unprofitable 2.02%
2 Holdings Count (8%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
48.5%
Top 10
68.5%
Top 25
99.9%
50% Threshold
Top 6
The top 10 holdings account for 68.5% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

8 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (17.7%+)
High (45.9%+)
Top (63.6%+)

Country Breakdown

Max: 70.62%
US US US
70.62%
IE IE IE
9.55%
CH CH CH
9.20%
GB GB GB
3.51%
AU AU AU
2.52%
IT IT IT
2.22%
DK DK DK
1.86%
CN CN CN
0.40%

Sector Distribution

1 Sector
Healthcare
99.88%

Industry Distribution

3 Industries
Medical Devices
77.86%
Medical Instruments & Supplies
19.80%
Medical Distribution
2.22%

Market Cap Distribution

25 Holdings Count
Large Cap (10B - 200B)
(9) 65.24%
Mid Cap (2B - 10B)
(9) 22.70%
Small / Micro Cap (< 2B)
(7) 11.94%
ende